Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment
出版年份 2012 全文链接
标题
Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 12, Pages 1789-1800
出版商
Informa Healthcare
发表日期
2012-09-20
DOI
10.1517/13543784.2012.724397
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
- (2012) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristic Resistance Mechanism ofMycobacterium tuberculosisto DC-159a, a New Respiratory Quinolone
- (2011) Jun-ichiro Sekiguchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of ClinicalMycobacterium tuberculosisIsolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
- (2011) J. W. C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of the Fluoroquinolone DC-159a in the Initial and Continuation Phases of Treatment of Murine Tuberculosis
- (2011) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
- (2011) R. Singla et al. EUROPEAN RESPIRATORY JOURNAL
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
- (2011) D. Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
- (2011) Nicolas Veziris et al. PLoS One
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nervous System Effects of Antituberculosis Therapy
- (2010) Joseph S. Kass et al. CNS DRUGS
- Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais - parte 2: fármacos de segunda linha
- (2010) Marcos Abdo Arbex et al. Jornal Brasileiro de Pneumologia
- Chemical modification of capuramycins to enhance antibacterial activity
- (2010) Elena Bogatcheva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance
- (2010) Giulia Manina et al. MOLECULAR MICROBIOLOGY
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis
- (2009) B. V. Nikonenko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthetic EthR inhibitors boost antituberculous activity of ethionamide
- (2009) Nicolas Willand et al. NATURE MEDICINE
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
- (2008) Reynaldo Dietze et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis*
- (2008) Rany Condos et al. CHEST
- Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?
- (2008) G. B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More